ehealth radio network
Community is Key:  The final push for herd immunity

Community is Key: The final push for herd immunity

July 1, 2021

 

Alexis_Hunter98ce2.jpeg

 

Alexis Hunter, Community Liaison for Wilmington Health, a physician-owned primary care and multi-specialty medical practice serving Wilmington and the Southeastern North Carolina area joins eHealth Radio and the COVID-19, Health Care and Health News Channels.


Listen to interview with host Eric Michaels & guest Alexis Hunter discuss the following:

  1. What current trends are we seeing with vaccinations across the U.S.?
  2. What has changed over the past six months that the vaccine has been available?
  3. How are rural/lower-income areas effected?
  4. Has one demographic been more hesitant than another?
  5. How are you continuing to get the word out in your community?

Alexis joined Wilmington Health, one of the largest independent, multi-specialty practices in North Carolina, in April 2020. Recruited as the first dedicated outreach employee for the organization, she focuses on building relationships with organizations and individuals in southeastern North Carolina. Alexis dedicates herself to Wilmington Health’s vision of aspiring to be the most trusted partner in healthcare, transforming the delivery system, and continually developing collaborative and innovative solutions that demonstrate quality, reduce the cost of care, and improve the patient experience.

Before joining Wilmington Health, she worked in administration for a private mental health practice. She works closely with area employers to ensure employees have access to expert healthcare. She also collaborates with outside providers, so that patients in the community have access to the providers that can best suit their healthcare needs.

 

wilmington_health9ocxx.jpeg

 

Website: wilmingtonhealth.com

Social Media Links:
Facebook: facebook.com/wilmingtonhealth 
Instagram: @wilmhealth
LinkedIn: linkedin.com/company/wilmington-health-associates

The way we experience healthcare has changed for good: A conversation with David McNeil of PatientPop

The way we experience healthcare has changed for good: A conversation with David McNeil of PatientPop

June 29, 2021

 

David_McNeilbjmnt.jpeg

 

David McNeil, President and COO of PatientPop, the first all-in-one practice growth platform joins eHealth Radio and the Health Care and Marketing Channels. On this episode, you will learn more about how technology is improving patient experience and helping practices grow.


Listen to interview with host Eric Michaels and guest David McNeil discuss the following:

  1. Can you introduce yourself, past companies you’ve worked at, and describe your role at PatientPop?
  2. Can you tell our listeners more about PatientPop and the solutions you provide for private practices?
  3. What are some of the pain points in healthcare that PatientPop is addressing?
  4. What is the biggest benefit to private practices with using PaitentPop's technology?
  5. Do you have any stories you can share with us about the successes of practices using PatientPop?
  6. What is in store for the future of PaitentPop?

David McNeil is President & COO at PatientPop, the market leader in practice growth technology platform that helps practices increase patient acquisition, retention and deliver exceptional patient experiences. With over a decade of SaaS leadership experience, David is responsible for leading all go-to-market functions and the growth strategy for the company.

Prior to assuming this role, David was Head of North America Sales at HubSpot responsible for driving growth across all segments. Over his time at HubSpot, David held various leadership positions including Global VP of Customer Selling, Global VP of Channel, and Global VP of Sales Strategy & Operations. Prior to joining HubSpot, David was responsible for leading the Business Development organization for Americas at Salesforce.com.

Over the years David has held several leadership roles building highly effective go-to-market teams that drive accelerated growth and deliver real value to prospects and customers. David is extremely passionate about building an inclusive, safe, and diverse culture where we people can grow together, win together and have fun together. He is a husband, a proud dad of four teenagers (and two dogs), and an active advisor to small/mid-size companies. He is also actively involved with several charitable organizations focused on the areas of cancer and mental health.

 

PatientPop_Logo.jpg

 

Website: patientpop.com

Social Media Links:
Facebook: facebook.com/PatientPopInc 
Instagram: instagram.com/patient_pop 
Twitter: twitter.com/patientpop

Vaccine Equity and the Race Towards Herd Immunity

Vaccine Equity and the Race Towards Herd Immunity

June 26, 2021

 

Linda_Odenigbo6gwls.jpeg

 

Dr. Linda Odenigbo, a Pediatrician at PriMED Physicians in Dayton Ohio joins eHealth Radio and the Health Care and Health News Channels. Throughout the vaccine rollout, Dr. Odenigbo and other Black colleagues have been actively working with the Black community in Dayton, specifically Dayton's Nigerian population to increase vaccine confidence.


Listen to interview with host Eric Michaels and guest Dr. Linda Odenigbo discuss the following:

  1. Throughout the vaccine rollout, primary care physicians have been working hard to increase vaccine confidence, especially among people of color. Can you tell us about some of the concerns surrounding the COVID-19 vaccines that you have heard from patients?
  2. I know that you and other Black physicians at PriMED did a lot of outreach work to increase vaccine confidence, specifically within the Black community in Dayton. What were some of the ways that you and your colleagues engaged with the community?
  3. Of all of the phone calls and conversations you have had with patients, is there any one that sticks out the most?
  4. What trends have you been seeing most recently with vaccine hesitancy?
  5. President Joe Biden recently announced his plan to get 70% of Americans at least partially vaccinated by July 4. Do you feel positive about us reaching that goal?

Linda Odenigbo, MD, is a Pediatrician at PriMED Physicians in Dayton, Ohio. A graduate of University of Ilorin Medical School, Dr. Odenigbo trained and practiced internal medicine in Nigeria until 1991. She completed her Pediatric residency at Harlem Hospital New York and later worked at CHIC clinic, a federally funded health care center in Decatur, Illinois, before finally joining PriMED pediatrics in 2000. Dr. Odenigbo’s special interests include childhood allergic conditions, as well as female adolescent health issues.

 

PriMED_logoaryf7.png

 

Website: primedphysicians.com

Facebook: facebook.com/PrimedPhysicians

Joint Pain Exacerbated During COVID-19 Pandemic

Joint Pain Exacerbated During COVID-19 Pandemic

June 15, 2021

 

dr_richard_berger_2atifl.png

 

Dr. Richard Berger, M.D., a world-renowned orthopedic surgeon at Midwest Orthopedics at Rush and assistant professor at Rush University Medical Center, Chicago again joins eHealth Radio and the Orthopedic & Health News Channels. The pioneer of a minimally invasive technique, Dr. Berger was the first in the world to perform outpatient hip and knee replacement surgery and has done over 12,000 surgeries -- more than any other surgeon.


Listen to interview with host Eric Michaels and guest Dr. Richard Berger discuss the following:

  1. As an orthopedic surgeon, what trends have you been seeing with your patients during the pandemic?
  2. What can be done to offset joint pain? For listeners who are working from home and moving less …what recommendations do you have?
  3. ​I know that the pandemic has also led to patients putting off medical treatment or postponing surgeries, such as joint replacement. Can you tell us more about this?
  4. What message do you have to people who are delaying their care?
  5. For patients who are still putting off surgery, what would you say to them to ease their concerns? Why is now the time to get surgery?

Richard Berger, M.D., is a world-renowned orthopedic surgeon at Midwest Orthopedics at Rush and assistant professor at Rush University Medical Center, Chicago. He pioneered a minimally invasive hip and knee replacement that allows for a quicker and less painful recovery than traditional joint replacement. He also was the first in the world to perform outpatient hip and knee replacement surgery and has done over 12,000 surgeries -- more than any other surgeon. Patients come from all the world to have surgery from Dr. Berger, and they include elite athletes, politicians and celebrities.

 

Dr_Berger_LOGO6w7g5.jpg

Website: https://outpatienthipandknee.com

Social Media Links:
Facebook: facebook.com/DrRichardBerger 
Instagram: instagram.com/drrichardberger 
Twitter: @DrRichBerger 

The Future of Medicine is Now: Why one orthopedic surgeon is embracing telehealth

The Future of Medicine is Now: Why one orthopedic surgeon is embracing telehealth

June 5, 2021

 

dr_richard_berger_2atifl.png

 

Dr. Richard Berger, M.D., a world-renowned orthopedic surgeon at Midwest Orthopedics at Rush and assistant professor at Rush University Medical Center, Chicago joins eHealth Radio and the Orthopedic & Tele-medicine Channels. The pioneer of a minimally invasive technique, Dr. Berger was the first in the world to perform outpatient hip and knee replacement surgery and has done over 12,000 surgeries -- more than any other surgeon.


Listen to interview with host Eric Michaels and guest Dr. Richard Berger discuss the following:

  1. Can you tell us about your background? What got you started in orthopedics? What makes your approach to joint replacement unique? Who are the patients that you are normally seeing?
  2. During the pandemic, many physicians quickly pivoted to tele-health to continue seeing patients. Can you discuss this shift how it has affected your work with patients?
  3. Would you say that tele-health has allowed you to interact with patients in ways that you could not previously?
  4. How has tele-health led to greater convenience for your patients?
  5. Do you think that embracing tele-health during the pandemic led to greater success for you and your patients? Is Tele-health here to stay?

Richard Berger, M.D., is a world-renowned orthopedic surgeon at Midwest Orthopedics at Rush and assistant professor at Rush University Medical Center, Chicago. He pioneered a minimally invasive hip and knee replacement that allows for a quicker and less painful recovery than traditional joint replacement. He also was the first in the world to perform outpatient hip and knee replacement surgery and has done over 12,000 surgeries -- more than any other surgeon. Patients come from all the world to have surgery from Dr. Berger, and they include elite athletes, politicians and celebrities.

 

Dr_Berger_LOGO6w7g5.jpg

Website: https://outpatienthipandknee.com

Social Media Links:
Facebook: facebook.com/DrRichardBerger 
Instagram: instagram.com/drrichardberger 
Twitter: @DrRichBerger 

Reinventing Financial Navigation

Reinventing Financial Navigation

May 26, 2021

 

Srulik_Dvorsky8fyt2.png

 

Srulik Dvorsky, the CEO and Co-founder of TailorMed, a leading financial navigation technology company that helps patients remove financial barriers to care joins eHealth Radio and the Health News Channel.


Listen to interview with host Eric Michaels and guest Srulik Dvorsky discuss the following:

  1. What is TailorMed and what was the driving force behind founding the company?
  2. What unique need is TailorMed solving for patients and for health systems?
  3. What is the importance of price transparency in healthcare for the patient? For a health system?
  4. How is TailorMed improving patient experience?
  5. What is TailorMed doing to fight inequities in healthcare and level the playing field?
  6. How has the patient's financial burden impacted providers, particularly at a time when COVID-19 has led to a drop in patient volume?

Srulik Dvorsky is the co-founder and CEO of TailorMed, the leading financial navigation technology company that helps patients and healthcare providers remove financial barriers to care. After serving as the primary caretaker for several family members following a cancer diagnosis, he started TailorMed with a personal mission to leverage technology to remove barriers to care. He brings to the company more than a decade of experience in the medical device industry.

 

TailorMed_LOGO.jpg

Website: https://tailormed.co

Social Media Links:
Facebook: facebook.com/TailorMed.co  
Instagram: instagram.com/tailormed.co

Servicon, elevating the cleaning industry by provide healthy environments

Servicon, elevating the cleaning industry by provide healthy environments

May 14, 2021

 

Laurie_Sewell_26qo23.png

 

Laurie Sewell, President and CEO of Servicon, a leading environmental, custodial and maintenance company located in Southern California joins eHealth Radio and the Health News Channel.


Listen to interview with host Eric Michaels and guest Laurie Sewell discuss the following:

  1. Tell us about Servicon and its mission.
  2. How has Servicon as an EVS leader helped in the fight against COVID?
  3. How does Servicon prepare its custodian technicians to do their jobs optimally and in the best interests of society?
  4. How is Servicon a critical partner in healthcare?
  5. How does Servicon help hospitals?
  6. What are Servicon’s top priorities for the next 12 months?

Laurie Sewell is President and CEO of Servicon, a provider of exemplary custodial, environmental, and maintenance services for complex facilities.

Servicon partners with Fortune 500 companies in the healthcare, aerospace, manufacturing, commercial real estate, municipal and entertainment industries. Their purpose is to elevate the industry and provide healthy environments for people to thrive.

Considered a disrupter in an industry steeped in tradition, Sewell is shifting the focus from conventional concepts of custodial services to those that are driving wellness, sustainability, new analytics and employee engagement with innovative technologies and training.

At the helm of a diverse workforce of over 1,800 employees, Sewell is passionate about the concept that profit should be achieved through the focus on talent development at all levels of an organization.

Sewell has held positions on international, advisory and editorial boards in her industry. She was also a stakeholder in the development of the GS-42 Green Seal standard. She holds a MA in Organizational Behavior and operates her business under the belief that “it is always about the people.”

Servicon’s five decades of success is due to the alignment of their unique corporate culture with their strategy. They have succeeded in doing well by doing the right thing for all people involved.

 

Servicon_Logo_RGB_TAGLINE94p3a.jpg

 

Website: www.servicon.com

Social Media Links:
Facebook: facebook.com/ServiconSystemsCAJanitorial
Twitter: twitter.com/Servicon

Dr. Stephen Harrison Discusses Clinical Importance of FibroScan Technology

Dr. Stephen Harrison Discusses Clinical Importance of FibroScan Technology

May 8, 2021

 

sHarrison_May21.png

 

Dr. Stephen A. Harrison, gastroenterologist and hepatologist, joins eHealth Radio and the Health News & Technology Channels to discuss the role FibroScan technology has played in the management of patients with liver disease.


Listen to interview with host Eric Michaels and guest Dr. Stephen A. Harrison discuss the following:

  1. Please share with us the ongoing need for assessing liver stiffness and fat as part of a liver health assessment – and why the detection of fatty liver disease remains such a pressing challenge for Americans, especially during the COVID-19 pandemic.

  2. How does FibroScan tie into your clinical workflow? How might other clinicians be able to utilize it?

  3. Tell us about the successes you are seeing as a result of the FibroScan FAST score implementation and the research you’ve gathered from it.
  4. What work is being done to improve any previous high screen failure rates? Has there been any improvement since late phase clinical trials?

  5. Do you have any patient stories that you could share with us about the success of monitoring liver stiffness and fat with FibroScan?

  6. What will your focus be on continuing to bring awareness of NAFLD diagnosis and treatment in a post-pandemic world?

  7. Where do you see this research going in terms of the management of liver disease and improving outcomes for patients?

Dr. Stephen A. Harrison, M.D., FACP, FAASLD, retired COL, USA, MC, gastroenterologist and hepatologist, medical director of Pinnacle Clinical Research, and visiting professor of Hepatology, University of Oxford.

About Echosens

Echosens, the developer of FibroScan®, is an innovative high-technology company offering a full range of products and services supporting physicians in their assessment and management of patients with chronic liver diseases. FibroScan is supported by over 2,500 peer-reviewed publications and examinations are covered by Medicare, Medicaid and many insurance plans.

logo_echosens_gradient6xp78.png

Website: https://echosens.com

Social Media Links:
Facebook: facebook.com/fibroscan.echosens 
Linkedin: linkedin.com/company/echosens 
Youtube: youtube.com/user/EchosensTV

Bastille Delivers Zone Detection for Healthcare Sector

Bastille Delivers Zone Detection for Healthcare Sector

May 5, 2021

 

Bob_Baxley_20218895b.png

 

Bob Baxley, CTO at Bastille Networks a company that delivers enterprise threat detection through software-defined radio joins eHealth Radio and the Technology Channel.


Listen to interview with host Eric Michaels and guest Bob Baxley discuss the following:

  1. Can you provide our listeners a background on Bastille and why the company was created?
  2. What are some of the pain points in radio frequency that Bastille is addressing?
  3. How will radio frequency’s complexity in the workplace change as workers return based on the devices they bring and the devices that they may be asked to wear?
  4. What are the benefits of using Bastille's technology for zone detection to mitigate the unforeseen new threats from other contact tracing technologies?
  5. What are some steps that the healthcare industry can improve to protect facilities and patient data from adversaries?

For more than a decade, Dr. Bob Baxley has been a technology leader in implementing machine learning algorithms for software defined and cognitive radios. At Bastille, Bob serves as Chief Technology Officer where he leads the development of systems to sift through massive amounts of radio frequency data to protect enterprises from radio threats.

Prior to joining Bastille, Bob was the Director of the Software Defined Radio Lab at Georgia Tech, where he led basic and applied research projects for organizations including NSF, ONR, Army, DoD, Air Force and DARPA. He has published more than 100 peer-reviewed papers and patents, is the receipt of various research awards, and is a Senior Member of the IEEE. He also led the GTRI team that competed in the DARPA Spectrum Challenge and placed second out of 90 teams.

 

Bastille_Logo68yg6.png

 

Website: www.bastille.net

Social Media Links:
Twitter: twitter.com/bastillenet 
Linkedin: linkedin.com/company/bastille-networks

Leveraging Precision Medicine to Improve Lives, Reduce Healthcare Costs, and Simplify Decision-making

Leveraging Precision Medicine to Improve Lives, Reduce Healthcare Costs, and Simplify Decision-making

April 23, 2021

 

Scott_Megill9ccbv.png

 

Scott Megill, President and CEO at Coriell Life Sciences, a precision medicine company using genetic science and research to improve lives, reduce healthcare costs, and simplify decision-making for its customers joins eHealth Radio and the Health News Channel.


Listen to interview with host Eric Michaels & guest Scott Megill discuss the following:

  1. Who is Coriell Life Sciences?
  2. How does Coriell Life Sciences partner with the healthcare community to deliver paths to better health?
  3. What makes Coriell Life Sciences unique?
  4. How can individuals benefit from participating in Coriell Life Sciences’ medication safety program?
  5. What’s the biggest opportunity for the healthcare ecosystem when it comes to personalized medicine?

Medications don’t work for everyone. Nearly one-third of U.S. adults take five or more prescription drugs and, even when taken correctly, they can be dangerous for many. Payers, providers, and patients bear the financial and physical burdens of inappropriate, ineffective drugs. Each year medication errors lead to 128,000 deaths and the costs of medication-associated errors exceed $40 billion in the U.S. alone. The cost of getting medications wrong reverberates through the healthcare service model and echoes back as wasted resources, time, and poor health.

For hundreds of medications, successful treatment is directly related to an individual’s DNA. Natural variation in our genetic code can cause the same drug to produce different effects on different people. The science of pharmacogenomics (PGx) can now assist in assessing how each person will respond to medications, however, DNA testing alone is not sufficient. That’s why Coriell Life Sciences (CLS) leverages advanced, proprietary technology to bridge the gap between genetic knowledge and clinical application. Building on six decades of research, CLS developed a cutting-edge bioinformatics solution that interprets pharmacogenomic laboratory results and couples them with traditional medication management risk factors to deliver a dynamic regimen modeling tool.

Driving innovation in precision medicine, CLS unlocks the power of genetic science to provide actionable insights for employers, payers, healthcare providers, physicians, pharmacists, laboratories, and patients, that enable more effective and efficient care.

Backed by rigorous scientific methodology, Corigen™, CLS’ population-scale medication safety program, is the most comprehensive medication safety solution on the market. This novel solution is powered by CLS’s real-time medication decision support modeling tool, GeneDose LIVE. This unique system provides physicians with updated medication risk information for their patients’ current medication regimen and offers alternatives for safer therapy, all in real-time. GeneDose LIVE also provides risk analysis of non-genetic factors such as lifestyle, drug interactions, age-related risks, and other concerns, along with a personalized medication action plan (MAP) that reveals which medications are best suited for an individual.

By matching people with the right medications, CLS enables patients to benefit from fewer hospitalizations, less unneeded testing, and reduced doctor’s visits, ultimately decreasing healthcare costs. Most importantly, CLS reduces costly trial-and-error experimentation and speeds patients’ return to good health.

Recognized as a leader in precision medicine and health innovation—including IBM’s Entrepreneur of the Year—CLS leverages its influence to advocate for the advancement of precision medicine. The organization is highly active with the American Society of Pharmacovigilance, the Personalized Medicine Coalition, a signing member of the Get the Medications Right Institute, and passionate about educating stakeholder groups through the Population Health Colloquium, Health Action Council, Employer Health Innovation Roundtable, and various other platforms.

As CLS collaborates with major healthcare providers to empower the most precise medical care, the organization is continually pushing the boundaries of what’s possible—serving as the gold standard in knowledge and understanding of pharmacogenomics.

 

1bf016d2368a89e1ca449231d70869a79ca8da4c.png

 

Website: https://coriell.com

Linkedin Links:
Company LinkedIn: linkedin.com/company/corielllife
Personal LinkedIn: linkedin.com/in/scottmegill

Podbean App

Play this podcast on Podbean App